ORGANIC ANION–TRANSPORTING POLYPEPTIDES - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 100

lowering capabilities and basal sterol serum levels. Naunyn Schmiedebergs Arch Phar-
macol 373(1):45-50.
91. Badagnani I, Castro RA, Taylor TR, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns
SJ, Ferrin TE, Carlson EJ, et al. 2006. Interaction of methotrexate with organic-anion
transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther 318(2):521-
529.
92. Letschert K, Keppler D, K onig J. 2004. Mutations in the SLCO1B3 gene affecting the
substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Phar-
macogenetics 14(7):441-452.
93. Tsujimoto M, Hirata S, Dan Y, Ohtani H, Sawada Y. 2006. Polymorphisms and link-
age disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects. Drug Metab
Pharmacokinet 21(2):165-169.
94. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.
2002. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake
to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71(1):11-20.
95. Simonson SG, Raza A, Martin PD, Mitchell PD, Jarcho JA, Brown CD, Windass AS,
Schneck DW. 2004. Rosuvastatin pharmacokinetics in heart transplant recipients admin-
istered an antirejection regimen including cyclosporine. Clin Pharmacol Ther 76(2):167-
177.
96. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. 2001. Hepatic uptake of bilirubin and its
conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276(13):9626-
9630.
97. Briz O, Serrano MA, MacIas RI, Gonzalez-Gallego J, Marin JJ. 2003. Role of or-
ganic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human
placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J 371(Pt
3):897-905.
98. Acocella G, Nicolis FB, Tenconi LT. 1965. The effect of an intravenous infusion of
rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in
man. Gastroenterology 49(5):521-525.
99. Campbell SD, de Morais SM, Xu JJ. 2004. Inhibition of human organic anion transporting
polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia. Chem Biol
Interact 150(2):179-187.
100. Wang P, Kim RB, Chowdhury JR, Wolkoff AW. 2003. The human organic anion
transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem
278(23):20695-20699.
101. Passamonti S, Terdoslavich M, Margon A, Cocolo A, Medic N, Micali F, Decorti
G, Franko M. 2005. Uptake of bilirubin into HepG2 cells assayed by thermal lens
spectroscopy. Function of bilitranslocase. FEBS J 272(21):5522-5535.
102. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. 2004. Risk factors for
severe hyperbilirubinemia in neonates. Pediatr Res 56(5):682-689.
103. Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi
S, Otsubo K, Sugiyama Y. 2004. Influence of common variants in the pharmacokinetic
genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects.
Hepatol Res 30(2):91-95.
104. Huang CS, Huang MJ, Lin MS, Yang SS, Teng HC, Tang KS. 2005. Genetic factors related
to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genom 15(1):43-50.